Showing results (461-470 of 996) with videos related to
Sort By:
Pageof 100
Journal of Neuro-Oncology|January 1, 1983
Weekly Cisplatin during cranial irradiation for malignant melanoma metastatic to brainD J Stewart, L G Feun, M Maor, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 1, 1991
Single agent therapy for infections in cancer patients: a prospective randomized trial comparing three extended-spectrum cephalosporinsK V Rolston, P G Jones, V Fainstein, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Small cell bronchogenic carcinoma: factors associated with pneumonia during chemotherapyC L Dixon, M Valdivieso, T Umsawasdi, et al.Leukemia & Lymphoma|April 6, 2004
Outcome determinants of fusariosis in a tertiary care cancer center: the impact of neutrophil recoveryD P Kontoyiannis, G P Bodey, H Hanna, et al.The Journal of Pharmacology and Experimental Therapeutics|August 1, 1981
A radioimmunoassay for 5-methyltetrahydrohomofolateK L Fong, D H Ho, R S Benjamin, et al.Journal of Clinical Pharmacology|February 1, 1981
Clinical pharmacology of intramuscularly administered L-asparaginaseD H Ho, H Y Yap, N Brown, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1984
The natural history of gastric cancer and prognostic factors influencing survivalA Y Bedikian, T T Chen, N Khankhanian, et al.The Journal of Antimicrobial Chemotherapy|January 31, 2003
Pharmacodynamic and kinetic basis for the selection of pneumococcal resistance in the upper respiratory tractF Soriano, V Rodriguez-CerratoCancer|January 1, 1977
Bis chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanomaE M McKelvey, J K Luce, V K Vaitkevicius, et al.American Journal of Clinical Oncology|February 1, 1983
Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancerM Valdivieso, J R Stroehlein, A Y Bedikian, et al.Pageof 100